Miss Georgia McCaughan
Senior Research Associate

Miss Georgia McCaughan

BMedSc MBBS (University Medal) MMed (Clin Epi) FRACP FRCPA

Medicine & Health
School of Clinical Medicine

Specialties
 Clinical and Laboratory Haematology

Department
Haematology

Areas of Interest
Plasma cell disorders including multiple myeloma and AL amyloidosis

Roles
Staff Specialist Haematologist, St Vincent’s Public Hospital


VMO Haematologist, St Vincent’s Private Hospital


Senior Research Associate, University of New South Wales
 

Phone
02 9355 5656
Location
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst. NSW 2010
  • Journal articles | 2022
    Chai KL; Wellard C; Aoki N; Moore EM; Augustson B; Bapat A; Blacklock HA; Chng WJ; Cooke R; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso A; Wong K; Spencer A; Wood EM; McQuilten ZK, 2022, 'P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)', HemaSphere, vol. 6, pp. 1454 - 1455, http://dx.doi.org/10.1097/01.hs9.0000849148.93868.54
    Journal articles | 2022
    Jiang W; Clancy LE; Avdic S; Sutrave G; Street J; Simms R; McGuire HM; Patrick E; Chan AS; McCaughan G; Myers N; Micklethwaite KP; Antonenas V; Selim AG; Ritchie D; Bateman CM; Shaw PJ; Blyth E; Gottlieb DJ, 2022, 'Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant', Blood Advances, vol. 6, pp. 4949 - 4966, http://dx.doi.org/10.1182/bloodadvances.2022007103
    Journal articles | 2022
    Lasica M; Spencer A; Campbell P; Wallington-Gates C; Doo NW; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', Clinical Lymphoma Myeloma and Leukemia, vol. 22, pp. S29 - S30, http://dx.doi.org/10.1016/s2152-2650(22)00321-4
    Journal articles | 2022
    Lasica M; Spencer A; Campbell P; Wallington-Gates C; Wong Doo N; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY.', HemaSphere, vol. 6, pp. 836 - 837, http://dx.doi.org/10.1097/01.hs9.0000846652.51254.ac
    Journal articles | 2022
    McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, vol. 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295
    Journal articles | 2022
    Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, vol. 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072
    Journal articles | 2021
    Bishop DC; Clancy LE; Simms R; Burgess J; Mathew G; Moezzi L; Street JA; Sutrave G; Atkins E; McGuire HM; Gloss BS; Lee K; Jiang W; Maddock K; McCaughan G; Avdic S; Antonenas V; O'Brien TA; Shaw PJ; Irving DO; Gottlieb DJ; Blyth E; Micklethwaite KP, 2021, 'Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells', Blood, vol. 138, pp. 1504 - 1509, http://dx.doi.org/10.1182/blood.2021010813
    Journal articles | 2021
    Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, vol. 138, http://dx.doi.org/10.1182/blood-2021-154028
    Journal articles | 2021
    Chai KL; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, vol. 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622
    Journal articles | 2021
    Hung D; Lenton D; Eslick R; Blennerhassett R; Joshi M; McCaughan G; Day S; Wright D, 2021, 'Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma', Genes Chromosomes and Cancer, vol. 60, pp. 668 - 677, http://dx.doi.org/10.1002/gcc.22975
    Journal articles | 2021
    McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, vol. 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247
    Journal articles | 2021
    McCaughan G; Jarvis S; Joseph J, 2021, 'Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series', Pathology, vol. 53, pp. 798 - 800, http://dx.doi.org/10.1016/j.pathol.2020.11.005
    Journal articles | 2021
    McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, vol. 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8
    Journal articles | 2021
    McCaughan GJ; Tran S; Durrant S; Harrison S; Morton J; Horvath N; Spencer A; Kerridge IH; Ke Er JA; Barge L; Bryant A; Filshie R; Choong E; Lai HC; Tiley C; Mills A; Butler A; Moore J; Hertzberg M; Kennedy G; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee C; Kalff A; Xia W; Hamad N, 2021, 'Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, vol. 27, pp. S399 - S401, http://dx.doi.org/10.1016/s2666-6367(21)00515-7
    Journal articles | 2021
    McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, vol. 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9
    Journal articles | 2021
    Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, vol. 138, http://dx.doi.org/10.1182/blood-2021-149354
    Journal articles | 2020
    Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, vol. 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859
    Journal articles | 2020
    McCaughan GJ; Crowther HJ; Chen V; Chunilal SD; Merriman E; Bortz H; Young L; Tran HA; Yuen HLA; Curnow J, 2020, 'Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes', Blood, vol. 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-143150
    Journal articles | 2020
    McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Blood, vol. 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991
    Journal articles | 2020
    McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269
    Journal articles | 2019
    Blennerhassett R; McCaughan G; Tegg E, 2019, 'Massive Splenomegaly, An Unexpected Diagnosis', Pathology, vol. 51, pp. S41 - S41, http://dx.doi.org/10.1016/j.pathol.2018.12.091
    Journal articles | 2018
    Blennerhassett R; McCaughan G; Tegg E, 2018, 'An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly', Pathology, vol. 50, pp. 773 - 775, http://dx.doi.org/10.1016/j.pathol.2018.05.007
    Journal articles | 2018
    Favaloro EJ; McCaughan G; Mohammed S; Lau KKE; Gemmell R; Cavanaugh L; Donikian D; Kondo M; Brighton T; Pasalic L, 2018, 'HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia', Pathology, vol. 50, pp. 426 - 436, http://dx.doi.org/10.1016/j.pathol.2017.11.089
    Journal articles | 2018
    Favaloro EJ; McCaughan GJB; Mohammed S; Pasalic L, 2018, 'Anticoagulation therapy in Australia', Annals of Blood, vol. 3, pp. 48 - 48, http://dx.doi.org/10.21037/aob.2018.12.02
    Journal articles | 2018
    McCaughan GJB; Favaloro EJ; Pasalic L; Curnow J, 2018, 'Anticoagulation at the extremes of body weight: choices and dosing', Expert Review of Hematology, vol. 11, pp. 817 - 828, http://dx.doi.org/10.1080/17474086.2018.1517040
    Journal articles | 2017
    Favaloro EJ; McCaughan G; Pasalic L, 2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, vol. 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005
    Journal articles | 2017
    McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, vol. 2017, http://dx.doi.org/10.1136/bcr-2017-223016
    Journal articles | 2016
    McCaughan GJB; Fulham MJ; Mahar A; Soper J; Hong AM; Stalley PD; Tattersall MHN; Bhadri VA, 2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, vol. 9, http://dx.doi.org/10.1186/s13045-016-0278-x
    Journal articles | 2013
    Kiely BE; McCaughan G; Christodoulou S; Beale PJ; Grimison P; Trotman J; Tattersall MHN; Stockler MR, 2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, vol. 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4
    Journal articles | 2013
    Mccaughan GJ; Blinman PL; Boyer MJ; Stockler MR, 2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, vol. 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x
    Journal articles | 2012
    Stockler MR; Kiely BE; McCaughan GJ; Christodoulou S; Beale PJ; Trotman J; Grimison P; Tattersall MHN, 2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, vol. 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126
  • Conference Abstracts | 2022
    Gorrie N; McCaughan G; Carroll A; Jabbour A; Kotlyar E; Fatkin D; Bart N, 2022, 'Role of Endomyocardial Biopsy and Mass Spectrometry for Precision in Cardiac Amyloid Subtyping: A Case Series', in Heart, Lung and Circulation, Elsevier BV, Vol. 31, pp. S99 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.123
    Conference Abstracts | 2021
    Quach H; Lasica M; Routledge D; Kalff A; Lim A; Low M; Estell JA; Sidiqi MH; Campbell P; Eek RW; Lai HC; McCaughan GJ; D'Rozario J; Browlett P; Rajagopal R; Heenan J; Murphy NE; Renwick W; Huan G; Mollee P, 2021, 'A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS8055
    Conference Papers | 2011
    Kiely BE; McCaughan G; Christodoulou S; Tattersall MHN; Beale P; Grimison P; Stockler MR, 2011, 'P5-15-02: Patients' Views about How Oncologists Should Explain Prognosis in Advanced Cancer.', in Cancer Research, American Association for Cancer Research (AACR), presented at Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX, http://dx.doi.org/10.1158/0008-5472.sabcs11-p5-15-02